Our website uses cookies
We use cookies to help provide you with a better service. You can cange your cookie settings at any time.
Otherwise, we will assume you're OK to continue. Learn more
Accept cookies
  • Home
  • Resources for people with severe haemophilia A without factor VIII inhibitors
  • Resources for people with haemophilia A and inhibitors to factor VIII
  • Video resources

Welcome to the Hemlibra Resource Centre

Here you’ll find additional information and resources to help support you with your Hemlibra treatment. You can also find printer friendly materials similar to those in your patient pack.

Resources for people with severe haemophilia A without factor VIII inhibitors

Resources for people with haemophilia A and inhibitors to factor VIII

Video resources
Terms and conditions|Privacy Policy

These resources are only intended for people who have been prescribed Hemlibra by their Healthcare Professional. Please exit this site if this does not apply to you

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard, or search for MHRA Yellow Card in the Google Play or Apple App Store. You should also report side effects to Roche Products Ltd by emailing the Roche Drug Safety Centre at welwyn.uk_dsc@roche.com or calling +44 (0) 1707 367554. By reporting side effects you can help provide more information on the safety of this medicine.

This site has been developed by Roche Products Limited and Chugai Pharma UK Ltd

This medicinal product is subject to additional monitoring

Job code: M-GB-00001766
Date of preparation: October 2020

Welcome to the Hemlibra
(emicizumab) resource centre
These resources are only intended for people living in the UK who have been prescribed Hemlibra by their Healthcare Professional.
By entering this site, you are confirming this applies to you. If this does not apply to you, please exit this page now.
Continue to site
Exit (This link will take you to the Roche corporate site)

This site has been developed by Roche Products Limited and Chugai Pharma UK Ltd

This medicinal product is subject to additional monitoring

Job code: M-GB-00001766
Date of preparation: October 2020